Mingzhao Xing
Laboratory for Cellular and Molecular Thyroid Research
Johns Hopkins University School of Medicine
Baltimore
MD 21287
USA
Name/email consistency: high
- Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. Xing, M., Alzahrani, A.S., Carson, K.A., Viola, D., Elisei, R., Bendlova, B., Yip, L., Mian, C., Vianello, F., Tuttle, R.M., Robenshtok, E., Fagin, J.A., Puxeddu, E., Fugazzola, L., Czarniecka, A., Jarzab, B., O'Neill, C.J., Sywak, M.S., Lam, A.K., Riesco-Eizaguirre, G., Santisteban, P., Nakayama, H., Tufano, R.P., Pai, S.I., Zeiger, M.A., Westra, W.H., Clark, D.P., Clifton-Bligh, R., Sidransky, D., Ladenson, P.W., Sykorova, V. JAMA (2013)
- The Akt Inhibitor MK2206 Synergizes, but Perifosine Antagonizes, the BRAFV600E Inhibitor PLX4032 and the MEK1/2 Inhibitor AZD6244 in the Inhibition of Thyroid Cancer Cells. Liu, R., Liu, D., Xing, M. J. Clin. Endocrinol. Metab. (2012)
- Prognostic utility of BRAF mutation in papillary thyroid cancer. Xing, M. Mol. Cell. Endocrinol. (2010)
- Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer. Xing, M. Thyroid (2010)
- BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. Xing, M., Clark, D., Guan, H., Ji, M., Dackiw, A., Carson, K.A., Kim, M., Tufaro, A., Ladenson, P., Zeiger, M., Tufano, R. J. Clin. Oncol. (2009)
- Recent advances in molecular biology of thyroid cancer and their clinical implications. Xing, M. Otolaryngol. Clin. North Am. (2008)
- BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Xing, M. Endocr. Rev. (2007)
- Gene methylation in thyroid tumorigenesis. Xing, M. Endocrinology (2007)
- BRAF mutation in thyroid cancer. Xing, M. Endocr. Relat. Cancer (2005)
- The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer. Xing, M. Clin. Endocrinol. (Oxf) (2005)
- BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. Xing, M., Westra, W.H., Tufano, R.P., Cohen, Y., Rosenbaum, E., Rhoden, K.J., Carson, K.A., Vasko, V., Larin, A., Tallini, G., Tolaney, S., Holt, E.H., Hui, P., Umbricht, C.B., Basaria, S., Ewertz, M., Tufaro, A.P., Califano, J.A., Ringel, M.D., Zeiger, M.A., Sidransky, D., Ladenson, P.W. J. Clin. Endocrinol. Metab. (2005)
- BRAF T1796A transversion mutation in various thyroid neoplasms. Xing, M., Vasko, V., Tallini, G., Larin, A., Wu, G., Udelsman, R., Ringel, M.D., Ladenson, P.W., Sidransky, D. J. Clin. Endocrinol. Metab. (2004)
- Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. Xing, M., Tufano, R.P., Tufaro, A.P., Basaria, S., Ewertz, M., Rosenbaum, E., Byrne, P.J., Wang, J., Sidransky, D., Ladenson, P.W. J. Clin. Endocrinol. Metab. (2004)